Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease multiple endocrine neoplasia type 1
Comorbidity C0079731|b-cell lymphoma
Sentences 3
PubMedID- 22563760 Impact of rituximab on stem cell mobilization following acvbp regimen in poor-risk patients with diffuse large b-cell lymphoma: results from a large cohort of patients.
PubMedID- 24752517 The combination of rituximab and cyclophosphamide, doxorubicin, vincristine and prednisone is the standard first-line treatment regimen in patients with diffuse large b-cell lymphoma (dlbcl); however, the available data do not apply to elderly or frail patients.
PubMedID- 20040700 Raltegravir-based haart regimen in a patient with large b-cell lymphoma.

Page: 1